Mabtas 100 mg Injection
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Mabtas 100 mg Injection

Mabtas 100 mg Injection

Mabtas 100 mg Injection contains rituximab 100 mg, a monoclonal antibody used in the treatment of certain blood cancers and autoimmune conditions. It is used for conditions such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Rituximab works by targeting the CD20 protein on B-cells and helping the immune system remove abnormal or overactive B-cells. Depending on the condition, it may be used alone or together with chemotherapy or other medicines as part of a prescribed treatment regimen. Patients require monitoring during and after infusion because infusion-related reactions, infections, and changes in blood-cell counts can occur. The dosage and treatment schedule are individualized by the specialist according to the disease, clinical response, and patient factors.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 100 mg
Concentration 10 mg/mL
Dosage Form Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 10 mL, 1 Vial

Product Also Known As

Mabtas 100mg Injection, Mabtas 100 mg Injection, Mabtas 100mg Vial, Rituximab 100mg Injection, Rituximab 100 mg Injection, Rituximab 100mg Infusion, Rituximab 10mg/mL Injection